ACADL and hepatocellular carcinoma: Here, we found that verteporfin effectively inhibited the growth of HCC organoids with low expression of ACADL, while had faint effect on organoids with high ACADL expression, indicating that verteporfin could be used as a precise medicine in human HCC therapy.